Trulieve Cannabis (NYSE:TRLV) CEO Kim Rivers Sells 300,000 Shares of Stock

Trulieve Cannabis Corp. (NYSE:TRLV) CEO Kim Rivers sold 300,000 shares of the firm’s stock in a transaction dated Thursday, June 25th. The shares were sold at an average price of $8.17, for a total transaction of $2,451,000.00. Following the completion of the transaction, the chief executive officer directly owned 1,613,724 shares in the company, valued at $13,184,125.08. This represents a 15.68% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Trulieve Cannabis Trading Up 0.7%

TRLV stock opened at $8.56 on Friday. Trulieve Cannabis Corp. has a 12-month low of $3.50 and a 12-month high of $13.28.

Analysts Set New Price Targets

Several analysts recently commented on TRLV shares. Zacks Research upgraded Trulieve Cannabis to a “hold” rating in a research report on Thursday, June 18th. Weiss Ratings began coverage on Trulieve Cannabis in a report on Tuesday, June 16th. They issued a “sell (d-)” rating on the stock. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Reduce”.

Trulieve Cannabis Company Profile

Trulieve Cannabis Corp. is a vertically integrated cannabis company focused on the cultivation, processing, and retail sale of medical and adult-use cannabis products. The company offers a range of products that may include flower, pre-rolls, concentrates, edibles, vape products, and topicals through its dispensary network and branded product portfolio.

Trulieve’s operations have been centered primarily in the United States, with a strong presence in Florida and additional markets in other states where cannabis is legally regulated.